Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8168705
Reference Type
Journal Article
Title
De behandeling van malaria
Author(s)
Kager, PA; Zijlmans, CWR; Boele Van Hensbroek, M; Wetsteyn, J
Year
1997
Is Peer Reviewed?
1
Journal
Nederlands Tijdschrift voor Geneeskunde
ISSN:
0028-2162
EISSN:
1876-8784
Volume
141
Issue
37
Page Numbers
1774-1778
Language
Dutch
Abstract
The diagnosis of malaria should include the species involved and in case of P. falciparum infection the parasitaemia index: the percentage of the infected red cells. P. vivax, ovale and malariae infection are treated with chloroquine, in case of P. vivax and ovale malaria followed by primaquine. Mefloquine and halofantrine are indicated for chloroquine-resistant vivax infections. Advice on management and treatment is different for mild and severe (⤠5% infected erythrocytes or presence of complications) P. falciparum infections. Mild infections may be treated on an outpatient basis. In severe infections quinine has to be started immediately, while frequent checks of vital functions and blood parameters are indicated. New treatment options are the use of artemisinine (preparations) or atovaquon, both efficacious and low in adverse effects and toxicity.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity